| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5454abd09f216530c44daae0e81afa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a9eeed1a04df7d7d6f29bfccf96a2a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eef8e8c93d8e62496616973e3e4923e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7e5358a2262155aae876583f5ea597f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_687d86fb1c8e0458f5513cc9b3a04368
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480645f4634e4830ad45eb6655cd4275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5ec0175fc24ad64a4c8b8ea919f0580 |
| publicationDate |
2020-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020038355-A1 |
| titleOfInvention |
Use of tim-3 antibody in preparation of medicines for treating tumors |
| abstract |
Disclosed is use of a TIM-3 antibody in preparation of medicines for treating tumors. Specifically, provided is use of the TIM-3 antibody or an antigen-binding fragment thereof in preparation of medicines for treating non-small cell lung cancer, the TIM-3 antibody containing a heavy chain variable region shown in SEQ ID NO: 33 and a light chain variable region shown in SEQ ID NO: 36. Further, also provided is use of the TIM-3 antibody or the antigen-binding fragment thereof and a PD-1 antibody or an antigen-binding fragment thereof in joint preparation of medicines for treating tumors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021144657-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021079188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021079195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022223048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021123902-A1 |
| priorityDate |
2018-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |